Dimitry Sa Nuyten is Chief Medical Officer of Arcus Biosciences, Inc.. Currently has a direct ownership of 94,933 shares of RCUS, which is worth approximately $1.59 Million. The most recent transaction as insider was on Sep 15, 2024, when has been sold 5,385 shares (Common Stock) at a price of $17.95 per share, resulting in proceeds of $96,660. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 94.9K
4.3% 3M change
29.0% 12M change
Total Value Held $1.59 Million

Dimitry SA Nuyten Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 15 2024
SELL
Payment of exercise price or tax liability
$96,660 $17.95 p/Share
5,385 Reduced 5.37%
94,933 Common Stock
Jan 23 2024
BUY
Grant, award, or other acquisition
-
28,000 Added 22.01%
99,195 Common Stock
Dec 19 2023
SELL
Sale (or disposition) back to the issuer
$27,858 $18.09 p/Share
1,540 Reduced 2.12%
71,195 Common Stock
Dec 18 2023
SELL
Sale (or disposition) back to the issuer
$26,734 $17.74 p/Share
1,507 Reduced 2.03%
72,735 Common Stock
Sep 18 2023
SELL
Sale (or disposition) back to the issuer
$75,643 $20.4 p/Share
3,708 Reduced 4.8%
73,591 Common Stock
Jan 23 2023
BUY
Grant, award, or other acquisition
-
34,000 Added 30.77%
76,500 Common Stock
Aug 23 2022
BUY
Grant, award, or other acquisition
-
42,500 Added 50.0%
42,500 Common Stock
DSN

Dimitry Sa Nuyten

Chief Medical Officer
Hayward, CA

Track Institutional and Insider Activities on RCUS

Follow Arcus Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RCUS shares.

Notify only if

Insider Trading

Get notified when an Arcus Biosciences, Inc. insider buys or sells RCUS shares.

Notify only if

News

Receive news related to Arcus Biosciences, Inc.

Track Activities on RCUS